Evidence map›Paper›PMID 15879554›Full record

ArticleGenes & development2005

Lozenge directly activates argos and klumpfuss to regulate programmed cell death.

Jill Wildonger, Alona Sosinsky, Barry Honig, Richard S Mann

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Genes & development, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Regulatory mechanisms of EGFR signalling during Drosophila eye development.Cellular and molecular life sciences : CMLS · 2016
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Myeloid leukemia factor is a conserved regulator of RUNX transcription factor activity involved in hematopoiesis.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jill WildongerCenter for Neurobiology and Behavior, Howard Hughes Medical Institute, Columbia University Medical School, New York, NY 10032, USA.
Alona Sosinsky
Barry Honig
Richard S Mann
Columbia University · USHoward Hughes Medical Institute · US

Funding

Proximo-distal Patterning inthe Drosophila appendegesR01GM058575 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MANN, RICHARD S · 1999 to 2016
$5.7M
DISSECTION OF ONCOGENIC PATHWAYS USING DROSOPHILAR01CA087379 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MANN, RICHARD S · 2000 to 2004
$1.3M
NCI NIH HHS R01 CA087379NIGMS NIH HHS R01 GM058575
6 · The paper itself

Abstract

We show that reducing the activity of the Drosophila Runx protein Lozenge (Lz) during pupal development causes a decrease in cell death in the eye. We identified Lz-binding sites in introns of argos (aos) and klumpfuss (klu) and demonstrate that these genes are directly activated targets of Lz. Loss of either aos or klu reduces cell death, suggesting that Lz promotes apoptosis at least in part by regulating aos and klu. These results provide novel insights into the control of programmed cell death (PCD) by Lz during Drosophila eye development.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsApoptosisBinding SitesComputational BiologyDNA-Binding ProteinsDrosophilaDrosophila ProteinsElectrophoretic Mobility Shift AssayEpistasis, GeneticEye ProteinsGenomicsGreen Fluorescent ProteinsImmunohistochemistryIn Situ Nick-End LabelingModels, Biologicalaos protein, DrosophilaDNA-Binding ProteinsDrosophila Proteinsenhanced green fluorescent proteinEye ProteinsGreen Fluorescent ProteinsKlu protein, Drosophilalz protein, DrosophilaNerve Tissue ProteinsTranscription Factors

Identifiers

PMID15879554
PMCPMC1091738
OpenAlexW2147298166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.